Share
4,372 Posts.
lightbulb Created with Sketch. 230
clock Created with Sketch.
06/04/17
22:53
Share
Originally posted by gordongreggy
↑
I am bewildered by MMJ, MDC, MXC market caps....its the BOTs, BDAs, ESEs and CPHs that are innovative, have higher margins, higher growth and its biopharmas going somewhere. The growers are basically a waste of time. Government and license constrained per country, heavy regulation and penetration.....
Search engines did well in internet 1.0 and basically no one survived.....The innovators always winout for Mark 2......Google, facebook, Amazon, Ebay.... or even tesla....Innovation and penetration always wins.
The Cannabanoids, synthetics will kill it in disease management, dermatology sectors....Biopharm is going to be massive. Multi Billion dollar industry growing. BDA and Linnea/Ipsen/Schwabe.de is one hell of a European/Pan Asian partnership......
The grower dependents should be at a discount to the innovating biopharm like BDA.
Very big days ahead. Plenty of catchup to come. Im expecting a breakout day any day now.
GG
Expand
Think about the time until a product is approved to sell. The amount of investment required.
A grower makes money regularly and can sell different products at different margins and also innovate as diversification of their existing business. No point having no cash flow.